Immuno-Oncology Divisions of Novartis and GlaxoSmithKline are Licensing from this Microcap Biotech – The Wall Street Transcript

The Wall Street TranscriptMarc Voigt is Executive Director and Chief Executive Officer of Immutep Limited. Mr. Voigt has served as the Chief Financial Officer and Chief Business Officer since 2012 and was appointed as CEO and Executive Director in July 2014. He has extensive … …read more Source:: MicroCap Stock News From Google News

from WordPress https://ift.tt/2EDMfos
via IFTTT

Newer Post Older Post